CAS RN: 2857-45-6
3β,19-Dihydroxyandrost-5-en-17-one
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2857-45-6
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
2857-45-6 / 3-hydroxy-10-(hydroxymethyl)-13-methyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one
Standard CAS: 2857-45-6
Multi CAS: No
Basic Information
copy
CAS
2857-45-6 copy
Multi CAS
No copy
Molecular Formula
C19H28O3 copy
Molecular Weight
304.400000 copy
Exact Mass
304.203845 copy
InChI
InChI=1S/C19H28O3/c1-18-8-7-16-14(15(18)4-5-17(18)22)3-2-12-10-13(21)6-9-19(12,16)11-20/h2,13-16,20-21H,3-11H2,1H3 copy
InChIKey
SGYCSWPEAHDOHE-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
22 copy
Fraction Csp3
0.84 copy
Rotatable bonds
1 copy
H-bond acceptors
3 copy
H-bond donors
2 copy
Molar refractivity
84.13 copy
TPSA
57.53 copy
LogP / Solubility
WLOGP
2.85 copy
MLOGP
2.52 copy
XLogP3
2 copy
Consensus LogP
2.46 copy
Log S (ESOL)
-3.46 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.12 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.13 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.55 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
6 copy